Prof Suzanne Garland

Details

Role Group Leader / Honorary Fellow Manager

Research area Infection, Immunity and Global Health

Group Molecular Microbiology

Professor Suzanne Garland is the Group Leader of the Molecular Microbiology group at MCRI.

Jin, F, Poynten, IM, Hillman, RJ, Law, C, Molano, M, Fairley, CK, Garland, SM, Templeton, DJ, Grulich, AE, Roberts, J, et al. Does use of anal cytology as a triage test improve the performance of high-risk human papillomavirus screening in gay and bisexual men for anal cancer prevention?. Int J Cancer 156(3) : 575 -586 2025
view publication
Garland, SM, Bhatla, N, Woo, YL, IPVS Policy Committee. IPVS STATEMENT on HPV vaccination: No longer supply constraints: Towards achieving WHO vaccine targets.. Vaccine 42(26) : 126400 2024
view publication
Balgovind, P, Aung, E, Shilling, H, Murray, GL, Molano, M, Garland, SM, Fairley, CK, Chen, MY, Hocking, JS, Ooi, C, et al. Human papillomavirus prevalence among Australian men aged 18-35 years in 2015-2018 according to vaccination status and sexual preference.. J Infect Dis 2024
view publication
Plummer, EL, Vodstrcil, LA, Danielewski, JA, Murray, GL, Doyle, ML, Latimer, RL, Fairley, CK, Chow, EPF, Garland, SM, Bradshaw, CS. Vaginal anaerobes are associated with cervicitis: A case-control study.. J Infect 89(2) : 106210 2024
view publication
Bolio, A, Waheed, D-E-N, Mugo, N, Garland, SM, Wanyoike, S, Njambe Tondo Opute, E, Singh, K, Mathur, P, Touray, K, Bhatla, N, et al. Overview of CHIC symposia series: Summary of Africa and South Asia symposia.. Vaccine 42 Suppl 2: S9 -S15 2024
view publication